insulin novonordisk novorapid flexpen solution injectable
novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u.i., corresp. 3.5 mg, glycerolum, zinci chloridum, dinatrii phosphas dihydricus, natrii chloridum, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, phenolum, metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.216 mg. - le diabète sucré - biotechnologika
insulin novonordisk novorapid penfill solution injectable
novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u. corresp. corresp. 3.5 mg, glycerolum, phenolum, metacresolum, zinci chloridum, natrii chloridum, dinatrii phosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.9 mg. - le diabète sucré - biotechnologika
insulin novonordisk novorapid solution injectable
novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u. corresp. 3.5 mg, glycerolum, phenolum, metacresolum, zinci chloridum, natrii chloridum, dinatrii phosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.9 mg. - le diabète sucré - biotechnologika
novo thirteen 2500 i.e. poudre et solvant pour solution injectable
novo nordisk pharma ag - catridecacogum - poudre et solvant pour solution injectable - praeparatio cryodesiccata: catridecacogum 15.00 mg corresp. catridecacogum 2500 u.i., histidinum, natrii chloridum, saccharum, polysorbatum 20, pro vitro corresp. natrium 3.65 mg. solvens: aqua ad iniectabile q.s. ad solutionem pro 3 ml. - blutungsprophylaxe - biotechnologika
novoseven 1 mg raumtemperaturstabiles injektionspräparat
novo nordisk pharma ag - eptacogum alfa (activatum) - raumtemperaturstabiles injektionspräparat - praeparatio cryodesiccata: eptacogum alfa (activatum) 1 mg, natrii chloridum, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, saccharum, mannitolum, antiox.: methioninum 0.5 mg, pro vitro. solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 1.12 ml. solutio reconstituta: eptacogum alfa (activatum) 1 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - hemmkörperhämophilie; schwere postpartale blutungen. - biotechnologika
novoseven 2 mg raumtemperaturstabiles injektionspräparat
novo nordisk pharma ag - eptacogum alfa (activatum) - raumtemperaturstabiles injektionspräparat - praeparatio cryodesiccata: eptacogum alfa (activatum) 2 mg, natrii chloridum, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, saccharum, mannitolum, antiox.: methioninum 1 mg, pro vitro. solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 2.1 ml. solutio reconstituta: eptacogum alfa (activatum) 2 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 2 ml. - hemmkörperhämophilie; schwere postpartale blutungen. - biotechnologika
novoseven 5 mg raumtemperaturstabiles injektionspräparat
novo nordisk pharma ag - eptacogum alfa (activatum) - raumtemperaturstabiles injektionspräparat - praeparatio cryodesiccata: eptacogum alfa (activatum) 5 mg, natrii chloridum, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, saccharum, mannitolum, antiox.: methioninum 2.5 mg, pro vitro. solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 5.17 ml. solutio reconstituta: eptacogum alfa (activatum) 5 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 5 ml. - hemmkörperhämophilie; schwere postpartale blutungen. - biotechnologika
novoseven 8 mg raumtemperaturstabiles injektionspräparat
novo nordisk pharma ag - eptacogum alfa (activatum) - raumtemperaturstabiles injektionspräparat - praeparatio cryodesiccata: eptacogum alfa (activatum) 8 mg, natrii chloridum, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, saccharum, mannitolum, antiox.: methioninum 4 mg, pro vitro. solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 8.3 ml. solutio reconstituta: eptacogum alfa (activatum) 8 mg, saccharum, aqua ad iniectabile q.s. ad solutionem pro 8 ml. - hemmkörperhämophilie; schwere postpartale blutungen. - biotechnologika
insulin novonordisk novorapid flextouch solution injectable
novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u.i., glycerolum, zincum ut zinci chloridum, natrii phosphates, natrii chloridum, conserv.: phenolum 1.5 mg, metacresolum 1.72 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - le diabète sucré - biotechnologika
insulin novonordisk novorapid pumpcart 100 e/ml solution injectable
novo nordisk pharma ag - insulinum aspartum - solution injectable - insulinum aspartum 100 u., glycerolum, zinci chloridum, dinatrii phosphas dihydricus, natrii chloridum, natrii hydroxidum, acidum hydrochloridum, phenolum, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3.216 mg. - le diabète sucré - biotechnologika